We are live on ! Find out more
COLL icon

Collegium Pharmaceutical
COLL

138 hedge funds and large institutions have $649M invested in Collegium Pharmaceutical in 2019 Q4 according to their latest regulatory filings, with 42 funds opening new positions, 40 increasing their positions, 41 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

433% more call options, than puts

Call options by funds: $1.26M | Put options by funds: $237K

100% more first-time investments, than exits

New positions opened: 42 | Existing positions closed: 21

88% more capital invested

Capital invested by funds: $345M → $649M (+$304M)

18% more funds holding

Funds holding: 117 → 138 (+21)

4.26% more ownership

Funds ownership: 89.72% → 93.98% (+4.3%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

2% less repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 41

Holders
138
Holders Change
+21
Holders Change %
+17.95%
% of All Funds
2.72%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
42
Increased
40
Reduced
41
Closed
21
Calls
$1.26M
Puts
$237K
Net Calls
+$1.03M
Net Calls Change
+$1.08M

Top Buyers

Rank Fund Capital Flow
1
EA
Emerald Advisers
Pennsylvania
+$13M
2
EMFAT
Emerald Mutual Fund Advisers Trust
Pennsylvania
+$12.7M
3
Renaissance Technologies
Renaissance Technologies
New York
+$8.42M
4
PA
Perceptive Advisors
New York
+$7.02M
5
DCM
Driehaus Capital Management
Illinois
+$3.72M

Top Sellers

Rank Fund Capital Flow
1
TGHSA
TPG Group Holdings (SBS) Advisors
Texas
-$16.5M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$11.5M
3
Prudential Financial
Prudential Financial
New Jersey
-$4.18M
4
SAM
Silvercrest Asset Management
New York
-$3.2M
5
RHJA
Rice Hall James & Associates
California
-$2.65M
Name Holding Trade Value Shares
Change 		Change in
Stake
PCMI
151
Paradigm Capital Management Inc
New York
– -$115K -10,000 Closed
BFEC
152
Benjamin F. Edwards & Company
Missouri
– -$69K -6,041 Closed
QT
153
Quantamental Technologies
New York
– -$39K -3,404 Closed
TC
154
Truvestments Capital
Florida
– -$5K -411 Closed
GI
155
Gradient Investments
Minnesota
– -$5K -404 Closed
PWMG
156
Prestige Wealth Management Group
New Jersey
– -$5K -400 Closed
TRCT
157
Tower Research Capital (TRC)
New York
– -$4K -337 Closed
APSP
158
Asset Planning Services (Pennsylvania)
Pennsylvania
– -$1K -100 Closed
LTFS
159
Ladenburg Thalmann Financial Services
Florida
– -$33 -2 -8%
3 4 5 6
7

COLL Hedge Fund Activity: Q4 2019 in Review

138 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in Collegium Pharmaceutical (COLL) for Q4 2019, worth a combined $649M — up 88% from $345M a quarter earlier.

Buyers outnumbered sellers: 42 funds opened new COLL positions and 21 closed out — a net gain of 21 holders — while 40 added to existing stakes and 41 trimmed.

The largest buyer was Emerald Advisers, opening a new position worth an estimated $13M. The largest seller was TPG Group Holdings (SBS) Advisors, exiting entirely with an estimated $16.5M sold.

  • 138 institutional investors held Collegium Pharmaceutical (COLL) as of Q4 2019, up from 117 in Q3 2019.
  • Funds reported $649M of Collegium Pharmaceutical stock for Q4 2019, up 88% quarter-over-quarter.
  • 42 funds opened new Collegium Pharmaceutical positions in Q4 2019 and 21 closed out, a net change of +21 holders.
  • The largest Collegium Pharmaceutical buyer in Q4 2019 was Emerald Advisers, an estimated $13M added.
  • The largest Collegium Pharmaceutical seller in Q4 2019 was TPG Group Holdings (SBS) Advisors, an estimated $16.5M sold.

Based on aggregated 13F filings for Q4 2019.